Cargando…

A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease

Despite decades of use of low protein diets (LPD) in the management of chronic kidney disease (CKD), their mechanisms of action are unclear. A reduced production of uremic toxins could contribute to the benefits of LPDs. Aromatic amino-acids (AA) are precursors of major uremic toxins such as p-cresy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barba, Christophe, Benoit, Bérengère, Bres, Emilie, Chanon, Stéphanie, Vieille-Marchiset, Aurélie, Pinteur, Claudie, Pesenti, Sandra, Glorieux, Griet, Picard, Cécile, Fouque, Denis, Soulage, Christophe O., Koppe, Laetitia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479128/ https://www.ncbi.nlm.nih.gov/pubmed/34584168 http://dx.doi.org/10.1038/s41598-021-98718-x

Ejemplares similares

Treatment with fibroblast growth factor 19 increases skeletal muscle fiber size, ameliorates metabolic perturbations and hepatic inflammation in 5/6 nephrectomized mice
por: Benoit, Berengère, et al.
Publicado: (2023)

Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
por: Barba, Christophe, et al.
Publicado: (2020)

The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease
por: Koppe, Laetitia, et al.
Publicado: (2018)

Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins
por: Hoibian, Elsa, et al.
Publicado: (2018)

The Relationship between Renal Function and Plasma Concentration of the Cachectic Factor Zinc-Alpha2-Glycoprotein (ZAG) in Adult Patients with Chronic Kidney Disease
por: Pelletier, Caroline C., et al.
Publicado: (2014)

Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy
por: Pereira, Sabrina da Conceição, et al.
Publicado: (2021)

Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers
por: Koppe, Laetitia, et al.
Publicado: (2019)

Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives
por: Koppe, Laetitia, et al.
Publicado: (2019)

Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
por: Luce, Mathilde, et al.
Publicado: (2018)

The intestine and the kidneys: a bad marriage can be hazardous
por: Vanholder, Raymond, et al.
Publicado: (2015)

Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells
por: Espi, Maxime, et al.
Publicado: (2020)

Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
por: Glorieux, Griet, et al.
Publicado: (2020)

Crescentic glomerulonephritis with anti-PR3 ANCA associated with Bartonella henselae infective endocarditis
por: Andrian, Titus, et al.
Publicado: (2022)

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
por: Florens, Nans, et al.
Publicado: (2016)

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
por: Vanholder, Raymond, et al.
Publicado: (2018)

COVID-19 vaccine acceptance among haemodialysis patients: a French survey
por: Andrian, Titus, et al.
Publicado: (2021)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
por: Neirynck, Nathalie, et al.
Publicado: (2015)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
por: Ebrahim, Zarina, et al.
Publicado: (2022)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
por: Boelaert, Jente, et al.
Publicado: (2016)

Evolution of renal function in patients with severe intestinal failure on home parenteral nutrition
por: Chalencon, Elodie, et al.
Publicado: (2020)

When the Renal (Function) Begins to Fall: A Mini-Review of Acute Kidney Injury Related to Acute Respiratory Distress Syndrome in Critically Ill Patients
por: Marchiset, Antoine, et al.
Publicado: (2022)

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease
por: Chinnappa, Shanmugakumar, et al.
Publicado: (2018)

Mild Therapeutic Hypothermia Protects from Acute and Chronic Renal Ischemia-Reperfusion Injury in Mice by Mitigated Mitochondrial Dysfunction and Modulation of Local and Systemic Inflammation
por: Schleef, Maxime, et al.
Publicado: (2022)

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
por: Gryp, Tessa, et al.
Publicado: (2020)

Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2013)

Impact of Estrogen Withdrawal and Replacement in Female Mice along the Intestinal Tract. Comparison of E2 Replacement with the Effect of a Mixture of Low Dose Pollutants
por: Pinteur, Claudie, et al.
Publicado: (2021)

Solitary kidney – a clinical challenge for endourologist
por: Bres-Niewada, Ewa
Publicado: (2016)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

Depot-specific differences in perilipin and hormone-sensitive lipase expression in lean and obese
por: Ray, Hind, et al.
Publicado: (2009)

Polyphenol-rich açaí seed extract exhibits reno-protective and anti-fibrotic activities in renal tubular cells and mice with kidney failure
por: Monteiro, Elisa Bernardes, et al.
Publicado: (2022)

Water-Soluble Vitamins and Trace Elements Losses during On-Line Hemodiafiltration
por: Bévier, Alban, et al.
Publicado: (2022)

Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease
por: El Amouri, Amina, et al.
Publicado: (2021)

Two Toxic Lipid Aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), Accumulate in Patients with Chronic Kidney Disease
por: Soulage, Christophe O., et al.
Publicado: (2020)

Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2015)

Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate
por: Pelletier, Caroline C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_86bq92tptjc5p9u1mh3c4sqv9u